Evaluation of the Effect of Tranexamic Acid Administration on Intraoperative Blood Loss in Patients Undergoing Gynecologic abdominal surgery; clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100102002963N42

Enrollment

Registered

2026-05-18

Start date

2026-06-06

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding during abdominal surgery in women. Intraoperative hemorrhage and hematoma of an endocrine system organ or structure complicating a procedure

Interventions

Intervention 1: Intervention group: Tranexamic Acid Syringe. Intervention 2: Control group: Placebo Syringe.

Eligibility

Sex/Gender

Female

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: All female patients aged 35-70 years, ASA class I, II, candidates for gynecological abdominal surgery

Exclusion criteria

Exclusion criteria: Patient's unwillingness to participate in the study - History of taking antiplatelet and anticoagulant drugs (aspirin and Plavix) - History of drug and psychotropic addiction - History of severe systemic diseases (cardiac, pulmonary, renal, hepatic) - History of DVT and pulmonary embolism

Design outcomes

Primary

Measure	Time frame
Bleeding rate during abdominal surgery in women. Timepoint: The volume of bleeding during surgery is estimated and recorded. Method of measurement: blood-soaked gauzes count, surgical field and blood volume in suction, urine volume during surgery, hematocrit before and after surgery, and drug side effects.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShekoufeh Behdad

Yazd University of Medical Sciences

drbehdad@ssu.ac.ir+98 35 1822 1386

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026